New Glycan Microarray Assay from CD BioGlyco Aims to Solve Long-Standing Analytical Challenge

Share this news:

-- CD BioGlyco, a biotechnology company focused on the advancement of glycobiology, reported the launch of its new Glycan Microarray Assay service, which is a solution to a long-standing problem in glycan analysis and research. Glycans have an important role, yet their study has been challenging due to the lack of flexible tools to analyze these very small and diverse structures.

CD BioGlyco is excited to bring this service and platform to life. The platform provides scientists with an unprecedented and comprehensive glycan library that ranges from simple monosaccharides to complex structures like human milk oligosaccharides (HMOs) and glycosaminoglycans (GAGs), facilitating broad and scalable interactions between glycan-binding proteins, antibodies, pathogens, and cells. The service gives scientists an expanded view for understanding complex biological mechanisms regulated by glycans.

"It's always been sort of a guessing game," said Anna, one of the lead presenters from CD BioGlyco. "When researchers are trying to find dependable ways to test glycan binding, the available methods are often too narrow or inflexible; our method provides enough flexibility without sacrificing accuracy."

CD BioGlyco has arrays to facilitate different study objectives, including 100 glycan and N-glycan arrays for overall structural profiling, sialic acid arrays to examine recognition and signalling, and HMO and GAG arrays to study complex oligosaccharides in human biology.

These methodologies are important for application areas such as:

  •  Drug development and target validation.
  •  Biotechnology R&D in developing new molecular pathways.
  •  Microbial glycobiology and immune response research.

CD BioGlyco aims to enable advanced glycan research and make it more widely available by combining precision, scale, and flexibility in one service. With this platform, the company hopes to eliminate technical barriers and increase the speed of development from drug discovery to basic research in glycan biology.

About Us: CD BioGlyco is a sub-brand of CD Bio Group. We offer a full range of glycobiology-related products, analysis, custom synthesis, and design to advance your glycobiology research.

Contact Info:
Name: Anna Bryan
Email: Send Email
Organization: CD BioGlyco
Website: https://www.bioglyco.com/

Release ID: 89171167

CONTACT ISSUER
Name: Anna Bryan
Email: Send Email
Organization: CD BioGlyco
REVIEWED BY
Editor Profile Picture
This content is reviewed by our News Editor, Diana W..

If you need any help with this piece of content, please contact us through our contact form
SUBSCRIBE FOR MORE